文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症的新型治疗策略:乌司他丁的多器官保护特性与临床潜力

A Novel Therapeutic Strategy for Sepsis: The Multiorgan Protective Properties and Clinical Potential of Ulineastatin.
PubMed 文献 · Shock · 2026-03-10
一句话结论综述指出乌司他丁通过抗炎、抗氧化及调控凋亡/自噬通路,在临床与临床前证据中减轻脓毒症所致肺、心、肝、脾、肠、肾损伤。

脓毒症是感染诱发的危及生命的全身炎症反应,进展为多器官功能障碍综合征时死亡率高。乌司他丁是一种具有抗炎和抗氧化特性的丝氨酸蛋白酶抑制剂,被视为脓毒症器官损伤的有前景的治疗候选药物。本文系统综述了乌司他丁对脓毒症多器官保护作用的最新进展,聚焦其调控关键信号通路、减少炎性细胞因子释放、抑制氧化应激及调节细胞凋亡/自噬的机制。临床与临床前证据显示乌司他丁可减轻肺、心、肝、脾、肠、肾等重要器官的损伤,为识别乌司他丁减轻脓毒症损伤的潜在治疗靶点提供了理论依据。

要点

  • 乌司他丁是丝氨酸蛋白酶抑制剂,具有抗炎和抗氧化特性,被视为脓毒症器官损伤有前景的治疗候选药物。
  • 综述聚焦乌司他丁调控关键信号通路、减少炎性细胞因子释放、抑制氧化应激及调节细胞凋亡/自噬的机制。
  • 临床与临床前证据显示乌司他丁可减轻脓毒症时肺、心、肝、脾、肠、肾的损伤。
  • 综述阐明了乌司他丁减轻脓毒症相关多器官功能障碍综合征的机制,为识别潜在治疗靶点提供理论依据。

研究设计与关键结果

  • 本文为系统综述,总结乌司他丁对脓毒症多器官保护作用的最新进展,聚焦其调控关键信号通路、减少炎性细胞因子释放、抑制氧化应激及调节细胞凋亡/自噬的机制。
  • 临床与临床前证据显示乌司他丁可减轻脓毒症时肺、心、肝、脾、肠、肾等重要器官的损伤。

证据类型、等级与局限

  • 证据类型:系统综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis, a life-threatening systemic inflammatory response induced by infection, remains a major therapeutic challenge with high mortality rates, especially when progressing to multiple organ dysfunction syndrome. Ulinastatin (UTI), a serine protease inhibitor with anti-inflammatory and antioxidative properties, has emerged as a promising therapeutic candidate for sepsis-induced organ injury. This article systematically reviews recent advances in the multiorgan protective effects of UTI against sepsis, focusing on its mechanisms through modulating key signaling pathways, reducing inflammatory cytokine release, inhibiting oxidative stress, and regulating cellular apoptosis/autophagy. Clinical and preclinical evidence demonstrates UTI's efficacy in alleviating injury in critical organs, including lungs, heart, liver, spleen, intestines, and kidneys. The current review clarifies the mechanism by which UTI mitigates sepsis-related multiple organ dysfunction syndrome and provides a theoretical basis for identifying potential therapeutic targets of UTI to mitigate sepsis injury.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Zhang H, Liang X, Liu XH, et al. A Novel Therapeutic Strategy for Sepsis: The Multiorgan Protective Properties and Clinical Potential of Ulineastatin. Shock. 2026. PMID: 42059826. doi:10.1097/SHK.0000000000002731

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。